VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 458.4 EUR -0.13% Market Closed

Market Cap: €47.6B

V	Vertex Pharmaceuticals Inc XHAM:VX1	US
	Novartis AG F:NOTA	CH
A	Applied Materials Inc DUS:AP2	US
S	Swiss Re AG F:SR9	CH
L	Lam Research Corp F:LAR	US
P	Pliant Therapeutics Inc F:9PT	US
B	Brinks Co SWB:PTY	US
	Hyundai Motor Co F:HYU	KR

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 26%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

47% > 25%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.